How we have helped people before.
We like numbers. So. $20bn. That is the amount of transactions we have advised on in the public markets. $50m is the amount we have raised for portfolio companies in the private equity marketplace. 0. Is the number of portfolio companies that are zombified or truly dead. 50. Is the number of applications we get a week to work with us. 80%. The number of start ups who fail to get beyond 18 months. 100%. The amount of our portfolio companies who are beyond 18 months. 42. Well, just because.
Sub Sector: Software/DLT
IZY Capital is delighted to have advised Omnitude on their recent strategic investment from Clinical Connex. The investment of up to $30m will be used to develop core product, scale sales and marketing and develop international operations in the UK, US and Europe.Read More
Sub Sector: Hardware
Izy advised Drone Evolution on a recent equity seed round from a syndicate of strategic angel investors. The management team has a proven track record in the industry, having formally run the Drone division for a major facilities management team. Capital is being used to develop a range of commercial applications for the commercial aviation and security markets.Read More
Sub Sector: Software/Clinical Support
TaperMD is a clinical decision support platform pioneered by some of the leading experts in medication management and polypharmacology. Izy is working with the team to develop the platform and assess the market opportunity. The product is currently in trials on three continents and will move to commercialisation in 2019.Read More